M C Ozelo Selected Research

Prothrombin (Factor II)

9/2007	A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in Brazil.
10/2000	The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M C Ozelo Research Topics

Disease

7	Hemophilia A (Haemophilia) 09/2017 - 09/2007
3	Hemorrhage 07/2017 - 01/2000
2	Hemophilia B (Haemophilia B) 07/2015 - 01/2000
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Bone Marrow Failure Disorders 01/2017
1	Hypersensitivity (Allergy) 07/2015
1	Sepsis (Septicemia) 09/2011
1	Vascular System Injuries 07/2010
1	Thrombosis (Thrombus) 10/2000
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

5	Factor VIII (Coagulation Factor VIII)IBA 11/2016 - 09/2011
4	Blood Coagulation Factors (Coagulation Factor)IBA 09/2017 - 07/2010
2	A-factor (Streptomyces)IBA 01/2014 - 01/2000
2	Prothrombin (Factor II)IBA 09/2007 - 10/2000
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Inosine Triphosphate (ITP)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 09/2015
1	AntibodiesIBA 09/2015
1	AnticoagulantsIBA 09/2011
1	LipopolysaccharidesIBA 09/2011
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 09/2011
1	recombinant FVIIa (rFVIIa)FDA Link 09/2007
1	Factor VIIa (Activated Factor VII)IBA 09/2007
1	factor V LeidenIBA 10/2000
1	DNA (Deoxyribonucleic Acid)IBA 01/2000

Therapy/Procedure

2	Therapeutics 01/2014 - 09/2007
1	Drug Therapy (Chemotherapy) 01/2017